Quantification of the tumor and stromal compartments demonstrated that the percentage of the stromal cell component of the tumors was lower in GDF15-KD tumors than in control tumors in both the PBS- and cisplatin-treated groups (Figure 5e,f). Here, GDF15 is linked to neoplasm.